Nursing care
Gestational Diabetes nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Gestational diabetes nursing care centres on the 24 to 28 week glucose tolerance screen, tight glucose monitoring, and anticipating the delivery complications that come from a large-for-gestational-age fetus. Priorities are blood glucose control, fetal growth surveillance, and teaching that treats this as a manageable condition rather than a lifelong diagnosis.
Recognising it at the bedside
Most patients with gestational diabetes have no symptoms at all, which is exactly why universal screening exists rather than symptom-based testing. When symptoms do appear, they mirror any hyperglycaemic state: increased thirst, frequent urination beyond the baseline increase of pregnancy, and fatigue that the patient attributes to being pregnant rather than to glucose control.
At the bedside, the clue is often in the chart rather than the patient's complaint: a fundal height measuring ahead of dates, polyhydramnios on ultrasound, or a fasting glucose that keeps creeping above 95 mg/dL on home monitoring. Ask specifically about risk factors on intake, including a prior macrosomic infant, obesity, a family history of type 2 diabetes, or a previous gestational diabetes diagnosis, since these push toward earlier first-trimester screening rather than waiting for the standard window.
Why the classic presentation misleads
Because gestational diabetes is usually asymptomatic, it is easy to assume a patient without complaints is not at risk, but the diagnosis is almost always made by the screening test itself, not by presenting symptoms. Skipping or delaying the 24 to 28 week oral glucose tolerance test on the assumption that the patient looks and feels fine is the most common way this diagnosis gets missed at the point where intervention still has time to work.
The other misleading pattern is treating gestational diabetes as a minor administrative diagnosis once the patient is started on diet or insulin. The real risk is downstream: fetal hyperinsulinaemia from sustained maternal hyperglycaemia drives macrosomia, and an infant weighing over 4,000 to 4,500 grams turns a straightforward vaginal delivery into one complicated by shoulder dystocia, birth trauma, or a caesarean decision made late in labour.
Priority nursing actions
Confirm the patient understands and is performing home glucose monitoring correctly, typically fasting and one or two hours postprandial, and review the log at every visit rather than accepting a verbal summary. Target ranges are commonly fasting below 95 mg/dL and one-hour postprandial below 140 mg/dL, though exact targets are set by the managing provider and can vary slightly by protocol.
Reinforce the diet and activity plan first, since many patients achieve control without medication, and escalate concerns to the provider when logs show persistent elevations despite adherence. If insulin or an oral agent is started, teach injection technique or dosing timing and reassess for hypoglycaemia symptoms, which patients often do not expect during pregnancy. From the third trimester onward, prioritise fetal growth assessment, coordinating growth ultrasounds and, in some protocols, non-stress testing to catch escalating macrosomia before it becomes a delivery problem.
Labs and diagnostics to expect
The defining test is the oral glucose tolerance test performed at 24 to 28 weeks, usually preceded by a one-hour 50-gram glucose challenge test as an initial screen; an elevated challenge result leads to the full three-hour, 100-gram diagnostic test. Patients with significant risk factors may be screened earlier in the first trimester using either the standard test or a fasting or HbA1c approach, depending on institutional protocol.
Once diagnosed, expect ongoing self-monitored blood glucose logs as the primary diagnostic tool through the rest of the pregnancy, alongside serial growth ultrasounds to track estimated fetal weight and amniotic fluid volume. An HbA1c is not used to diagnose gestational diabetes itself but may be checked if there is concern the patient had undiagnosed pre-existing diabetes before pregnancy.
Complications and their early signs
Macrosomia is the complication that defines the delivery risk profile: an estimated fetal weight climbing above the 90th percentile on serial ultrasounds signals a growing likelihood of shoulder dystocia, prolonged second stage, or a planned caesarean birth. Watch for fundal height consistently measuring several centimetres ahead of gestational age as an early bedside clue between scans.
Polyhydramnios is common and can precipitate preterm labour or cord prolapse at membrane rupture, so report excessive fundal height growth or maternal reports of severe shortness of breath from uterine overdistension. After birth, the neonate is at risk for hypoglycaemia because fetal insulin production remains high while the maternal glucose supply stops abruptly, so anticipate blood glucose checks in the first hours of life and early feeding to prevent it. Preeclampsia risk is also elevated in gestational diabetes, so continue routine blood pressure and proteinuria surveillance alongside glucose management.
Teaching that changes outcomes
Frame gestational diabetes as manageable rather than as a failure on the patient's part; guilt undermines adherence to monitoring and diet more than almost any other factor. Explain plainly why the fasting and postprandial targets matter: consistent control reduces the chance of a large baby and the delivery complications that come with it, which is a concrete, motivating reason beyond an abstract number.
Teach carbohydrate-consistent eating with smaller, more frequent meals rather than a generic diabetic diet handout, since pregnancy nausea and appetite changes make three large meals impractical for many patients. Make sure she understands that gestational diabetes typically resolves after delivery, but that it roughly doubles her lifetime risk of developing type 2 diabetes, so a postpartum glucose tolerance test around 4 to 12 weeks after birth and ongoing annual screening are not optional follow-up, they are the point of the diagnosis.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our maternity and newborn practice questions are the closest set to what this page covers.
Common questions
When is gestational diabetes screened for in pregnancy?
Universal screening happens at 24 to 28 weeks gestation, usually with a one-hour 50-gram glucose challenge test followed by a three-hour diagnostic test if the screen is elevated. Patients with significant risk factors, such as a prior macrosomic infant or obesity, are often screened earlier in the first trimester as well.
Why does gestational diabetes increase the risk of a difficult delivery?
Sustained maternal hyperglycaemia causes the fetus to produce excess insulin, which drives fat deposition and macrosomia. A larger-than-average infant raises the risk of shoulder dystocia, birth trauma and caesarean delivery, which is why glucose control during pregnancy directly affects delivery outcomes.
What blood glucose targets are used for gestational diabetes?
Common targets are a fasting glucose below 95 mg/dL and a one-hour postprandial glucose below 140 mg/dL, though exact numbers are set by the managing provider and protocols vary slightly. Nurses should confirm the specific targets documented in the patient's plan of care rather than assuming a single universal number.
Does gestational diabetes go away after birth?
Yes, blood glucose typically returns to normal after delivery once the placental hormones driving insulin resistance are gone. However, the condition roughly doubles the patient's lifetime risk of type 2 diabetes, so a postpartum glucose tolerance test and ongoing annual screening are recommended.
What NCLEX-style priorities come up most for gestational diabetes?
Expect questions on recognising the 24 to 28 week screening window, interpreting glucose logs against target ranges, anticipating macrosomia-related delivery complications, and teaching that prioritises consistent monitoring over blanket dietary restriction.